Isthmus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.50 M
as on 21-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 4.50 M
as on 21-12-2024
About Isthmus Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.50 M.
Shiv Dwivedi, Kavita, and Kulbhushan Rana serve as directors at the Company.
- CIN/LLPIN
U51909DL2013PTC259766
- Company No.
259766
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2013
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Isthmus Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Dwivedi  | Director | 25-Jul-2016 | Current |
| Kavita | Director | 10-Aug-2016 | Current |
| Kulbhushan Rana | Additional Director | 15-Dec-2016 | Current |
Financial Performance of Isthmus Pharmaceuticals.
Enhance accessibility to Isthmus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Isthmus Pharmaceuticals?
In 2016, Isthmus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2015 | Punjab National Bank | ₹4.50 M | Open |
How Many Employees Work at Isthmus Pharmaceuticals?
Unlock and access historical data on people associated with Isthmus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Isthmus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Isthmus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
